LPL Financial’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.24M Buy
11,083
+602
+6% +$69K ﹤0.01% 4310
2026
Q2
$1.2M Buy
10,481
+7,225
+222% +$621K ﹤0.01% 4265
2026
Q1
$271K Buy
+3,256
New +$258K ﹤0.01% 5257

Other funds holding KYMR

LPL Financial's KYMR Position: Q3 2026 in Review

LPL Financial increased its Kymera Therapeutics (KYMR) stake by 5.7% in Q3 2026, buying an estimated $69K and bringing the position to 11,083 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #4310.

LPL Financial first reported a position in KYMR in Q1 2026 and has held it in 3 quarters since. 215 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

  • LPL Financial held 11,083 shares of Kymera Therapeutics worth $1.24M as of Q3 2026.
  • LPL Financial bought 602 Kymera Therapeutics shares in Q3 2026, an estimated $69K.
  • Kymera Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #4310 holding.
  • LPL Financial first reported a position in Kymera Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 215 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.